Use of antidepressants in women after prophylactic bilateral oophorectomy: A Danish national cohort study.
Julie AbildgaardMagnus Glindvad AhlströmDorte Lisbeth NielsenGedske DaugaardBirgitte LindegaardNiels ObelØjvind LidegaardPublished in: Psycho-oncology (2020)
Women oophorectomized due to a family history of cancer at age ≤ 45 years were more likely to use antidepressants after bilateral oophorectomy. The increased use of antidepressants was limited to women treated with HRT. The study calls for further large-scale studies to understand how bilateral oophorectomy and concomitant HRT affects risk of depression in women with a family history of cancer.
Keyphrases
- breast cancer risk
- polycystic ovary syndrome
- major depressive disorder
- papillary thyroid
- pregnancy outcomes
- replacement therapy
- squamous cell
- case report
- cervical cancer screening
- depressive symptoms
- type diabetes
- pregnant women
- bipolar disorder
- squamous cell carcinoma
- metabolic syndrome
- adipose tissue
- lymph node metastasis
- young adults
- smoking cessation